Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C25H37NO2.CH4O3S |
| Molecular Weight | 479.672 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CS(O)(=O)=O.CN1CC[C@@]2(C)C3=CC(O)=CC=C3C[C@@H]1[C@@]2(C)CCC(=O)CCC4CCCC4
InChI
InChIKey=OKLHDYDHKBFXCK-HIYIHDMKSA-N
InChI=1S/C25H37NO2.CH4O3S/c1-24-14-15-26(3)23(16-19-9-11-21(28)17-22(19)24)25(24,2)13-12-20(27)10-8-18-6-4-5-7-18;1-5(2,3)4/h9,11,17-18,23,28H,4-8,10,12-16H2,1-3H3;1H3,(H,2,3,4)/t23-,24+,25-;/m1./s1
| Molecular Formula | C25H37NO2 |
| Molecular Weight | 383.5668 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | CH4O3S |
| Molecular Weight | 96.106 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Quadazocine is a substituted hexahydro-2,6-methano-3-benzazocine patented by Sterling Drug Inc. as analgesics and narcotic antagonist. Quadazocine is a potent antagonist of μ opioid receptor, less potent antagonist of κ and δ opioid receptors. In monkeys for whom responding was reinforced by food delivery, quadazocine blocks the rate-decreasing effects of the µ-agonists alfentanil and fentanyl with greater potency than it blocked the rate-decreasing effects of the κ-agonists U69,593
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Sex differences in opioid antinociception in rhesus monkeys: antagonism of fentanyl and U50,488 by quadazocine. | 2002-06 |
|
| Effects of flupenthixol and quadazocine on self-administration of speedball combinations of cocaine and heroin by rhesus monkeys. | 1999-10 |
|
| Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications. | 1998-03 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10435403
rhesus monkey: 0.32, 1, or 3.2 mg/kg
Route of Administration:
Intravenous
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:16:52 GMT 2025
by
admin
on
Mon Mar 31 18:16:52 GMT 2025
|
| Record UNII |
582SS143QX
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C67413
Created by
admin on Mon Mar 31 18:16:52 GMT 2025 , Edited by admin on Mon Mar 31 18:16:52 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000055040
Created by
admin on Mon Mar 31 18:16:52 GMT 2025 , Edited by admin on Mon Mar 31 18:16:52 GMT 2025
|
PRIMARY | |||
|
CHEMBL2111022
Created by
admin on Mon Mar 31 18:16:52 GMT 2025 , Edited by admin on Mon Mar 31 18:16:52 GMT 2025
|
PRIMARY | |||
|
DTXSID20991582
Created by
admin on Mon Mar 31 18:16:52 GMT 2025 , Edited by admin on Mon Mar 31 18:16:52 GMT 2025
|
PRIMARY | |||
|
24847759
Created by
admin on Mon Mar 31 18:16:52 GMT 2025 , Edited by admin on Mon Mar 31 18:16:52 GMT 2025
|
PRIMARY | |||
|
C80587
Created by
admin on Mon Mar 31 18:16:52 GMT 2025 , Edited by admin on Mon Mar 31 18:16:52 GMT 2025
|
PRIMARY | |||
|
582SS143QX
Created by
admin on Mon Mar 31 18:16:52 GMT 2025 , Edited by admin on Mon Mar 31 18:16:52 GMT 2025
|
PRIMARY | |||
|
71276-44-3
Created by
admin on Mon Mar 31 18:16:52 GMT 2025 , Edited by admin on Mon Mar 31 18:16:52 GMT 2025
|
PRIMARY | |||
|
W-25
Created by
admin on Mon Mar 31 18:16:52 GMT 2025 , Edited by admin on Mon Mar 31 18:16:52 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |